CATX
Perspective Therapeutics, Inc.
US
0
Insider buys (3m)
5
Insider sells (3m)
-$845.6K
Net value (3m)
—
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC · 10 percent owner | Sale | 42,129 | $3.11 |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC · 10 percent owner | Sale | 78,145 | $3.14 |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC · 10 percent owner | Sale | 35,769 | $3.12 |
| Sep 3, 2026 | Lantheus Holdings, Inc. · 10 percent owner | Sale | 35,769 | $3.12 |
| Sep 2, 2026 | Lantheus Holdings, Inc. · 10 percent owner | Sale | 78,145 | $3.14 |
| Mar 4, 2026 | Spoor Johan M. · director, officer: Chief Executive Officer | A-Award | 735,000 | $5.35 |
| Mar 4, 2026 | Martinez Maria E · director | A-Award | 50,000 | $5.35 |
| Mar 4, 2026 | Puhlmann Markus · officer: Chief Medical Officer | A-Award | 150,000 | $5.35 |
| Mar 4, 2026 | Hunt Jonathan Robert · officer: Chief Accounting Officer | A-Award | 90,000 | $5.35 |
| Mar 4, 2026 | Morich Frank · director | A-Award | 50,000 | $5.35 |
| Mar 4, 2026 | Williamson Robert F III · director | A-Award | 50,000 | $5.35 |
| Mar 4, 2026 | HENSON HEIDI · director | A-Award | 50,000 | $5.35 |
| Mar 4, 2026 | Woods Lori A · director | A-Award | 50,000 | $5.35 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 4, 2026